Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-03-27 | PRESSURE BIOSCIENCES INC | Urdea Michael S
(Director) |
J | Common Stock | A | 2872 | $0.16 - $0.16 | $459 |
2024-03-27 | PRESSURE BIOSCIENCES INC | SCHUMACHER RICHARD T
(President, CEO) |
J | Common Stock | A | 4554 | $0.16 - $0.16 | $728 |
2024-03-27 | PRESSURE BIOSCIENCES INC | Pollack Kevin
(Director) |
J | Common Stock | A | 2914 | $0.16 - $0.16 | $466 |
2024-03-27 | PRESSURE BIOSCIENCES INC | PETERSON JEFFREY N
(Director) |
J | COMMON STOCK | A | 11874 | $0.16 - $0.16 | $1,899 |
2024-03-27 | PRESSURE BIOSCIENCES INC | Mangiardi Vito J
(Director) |
J | COMMON STOCK | A | 625 | $0.16 - $0.16 | $100 |
2024-03-27 | PRESSURE BIOSCIENCES INC | Lazarev Alexander V
(Director) |
J | COMMON STOCK | A | 3755 | $0.16 - $0.16 | $600 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |